Figure 3From: Validation of the prognostic gene portfolio, ClinicoMolecular Triad Classification, using an independent prospective breast cancer cohort and external patient populationsThe association between clinicopathological variables and the three CMTC groups in the 4,851 overall breast cancers. (A) ER status, (B) HER2/TN status, (C) patient age, (D) tumor size, (E) lymph node status and (F) tumor grade. The P values were determined using the Chi-square test and Fisher's exact test. CMTC, ClinicoMolecular Triad Classification; ER, estrogen receptor; HER2, human epidermal growth factor receptor 2; TN, triple negative.Back to article page